An Open label multi-centric parallel randomized phase-IV non-inferiority study to evaluate the immunogenicity and safety of BE's Inactivated vero cell based Japanese Encephalitis Vaccine in ≥18 to ≤49 year old adult subjects in a two dose schedule in comparison with a licensed vero-cell culture derived Inactivated JE vaccine

Trial Profile

An Open label multi-centric parallel randomized phase-IV non-inferiority study to evaluate the immunogenicity and safety of BE's Inactivated vero cell based Japanese Encephalitis Vaccine in ≥18 to ≤49 year old adult subjects in a two dose schedule in comparison with a licensed vero-cell culture derived Inactivated JE vaccine

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Aug 2016

At a glance

  • Drugs Japanese encephalitis vaccine (Primary)
  • Indications Japanese encephalitis
  • Focus Pharmacodynamics
  • Sponsors Biological E Limited
  • Most Recent Events

    • 09 May 2012 Status changed from not yet recruiting to completed as reported by Clinical Trials Registry - India.
    • 23 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top